Free Republic

On January 24, 2022, The FDA revoked Emergency Use Authorizations (EUAs) for two COVID monoclonal antibody (McAb) treatments, bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab), made by Eli Lilly and Regeneron respectively. Again on March 25, the FDA revoked the EUA for sotrovimab, which is no longer authorized for use at this time in specified states and territories due to its ineffectiveness against the prevalence of Omicron sub-variants, such as BA.2 in those regions, brought in from overseas. Even these state-of-the-art McAbs can’t keep up with the rapidly mutating, highly transmissible COVID-19 variants. In doing so, the...

President Joe Biden’s administration has ordered 14 additional states to stop using a COVID-19 treatment made by GlaxoSmithKline and Vir Biotechnology. The Department of Health and Human Services (HHS) said March 30 it has paused shipments of the drug, sotrovimab, to the states, bringing the total number of states that are no longer receiving doses to 22. The states are Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin in the midwest; Arizona, California, Idaho, Oregon, and Washington state in the west; and Alaska and Hawaii. Previously, eight states in the northeast U.S. stopped receiving shipments of sotrovimab. The U.S. government purchased...

The U.S. Food and Drug Administration Monday rescinded its authorization for Covid-19 monoclonal antibody treatments made by Regeneron Pharmaceuticals and Eli Lilly after those treatments proved ineffective against the omicron variant, over a month after some hospitals voluntarily decided to stop offering the drugs. Monoclonal antibody treatments can prevent serious illness or hospitalization among high-risk Covid-19 patients by reinforcing the body’s natural immune response. Though Regeneron and Eli Lilly’s treatments worked against previous variants of the virus, omicron’s mutation in a spike protein targeted by the treatments all but eliminated their effectiveness. Over a month prior to the FDA’s Monday...

The Food and Drug Administration on Monday significantly restricted the use of a pair of monoclonal antibody treatments for COVID-19 because they are ineffective against the omicron. The agency said the therapies made by Eli Lilly and Regeneron should only be used in patients that have been infected with or exposed to a variant that is susceptible to the treatments.

As usual, the liberal-biased, fake news, mainstream media is lying and misrepresenting again. It was only days ago that I published my nationally syndicated (by Creators Syndicate) newspaper column titled, "Celebrate the Trump Christmas Miracle." In that column, I celebrated the greatest political comeback perhaps in history. Trump is back, winning in the polls, beating President Joe Biden. He's more popular and respected than Biden (or the pope) in polls. A majority of voters even agrees there was massive fraud in the 2020 election -- including 41 o percent Democrats. Trump has truly made both a political and financial comeback...

Sen. Rand Paul pinned blame for thousands of monthly coronavirus deaths on Dr. Anthony Fauci over his bias toward vaccines. "I would venture to say that thousands of people die in our country every month now from COVID because [Fauci’s] deemphasized the idea that there are therapeutics," Paul, who is also a physician, said in an interview on the Ron Paul Liberty Report published Monday. Paul explained that Fauci has a long history of a "bias" toward vaccines, stretching back to his work on AIDS. "I think Fauci is of the philosophy that vaccines are incredibly successful and are the...

WASHINGTON (AP) — As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain. For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital. But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which...

Former President Donald Trump urged his supporters on Sunday to get a booster shot of the COVID-19 vaccine to protect themselves against the Omicron variant, telling them they're "playing right into their hands" by doubting the vaccines. ... "Look, we did something that was historic," he said. "We saved tens of millions of lives worldwide. We, together, all of us, not me." ... "I think this would have been the Spanish Flu of 1917, where up to 100 million people died," he said. "This was going to ravage the country far beyond what it is right now."

German researchers have found that COVID-19 therapies developed by Eli Lilly (LLY.N) and Regeneron (REGN.O) lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus, likely reducing treatment options if the new variant prevails. Two groups of Germany based scientists separately found that protection from GlaxoSmithKline (GSK.L) and Vir's (VIR.O) antibody cocktail Xevudy held up when exposed to Omicron in lab experiments, but that this was not the case for Lilly's antibodies, bamlanivimab and etesevimab, and the antibodies in Regeneron's Ronapreve drug.

Regeneron Pharmaceuticals Inc announced on Monday that its antibody cocktail can severely slash the risk of being infected with COVID-19 for up to eight months. ... ...Late-stage trial data showed a single dose can lower the risk of contracting Covid by 81.6 percent between two and six-months after the cocktail is administered... ...'These results demonstrate that REGEN-COV has the potential to provide long-lasting immunity from SARS-CoV-2 infection, a result particularly important to those who do not respond to COVID-19 vaccines including people who are immunocompromised.' .. ...The new trial data, released today, looked at the antibody cocktail's efficacy between two...

Phase 3 trial results by biotech company Regeneron showed its new drug provides long-term protection against COVID-19, KTLA sister station KRON reported. A single dose of the antibody cocktail reduced the risk of contracting COVID-19 by 81.6% during months 2-8, according to results released Monday. Previously published results already showed its effectiveness within one month of getting the injection. Regeneron said none of the participants who were injected with a single dose of the ‘REGEN-COV’ antibody cocktail were hospitalized with COVID-19 during the eight-month trial run in collaboration with the National Institute of Allergy and Infectious Diseases. Meanwhile, six people...

Beloved young relative has covid. There is no Regeneron in the state. Offered Sotromab. Feedback? Never heard of it.

FDA expected to issue full emergency authorization for periodic antibody injections, or PrEP, to complement vaccinations A proud sports mom, Shantay Brown longs to pack into a crowded stadium for her son’s Ohio State football games and scream her face off over the action on the field. But as with so many other simple pleasures in the age of Covid-19, nothing is that simple for Brown. The 47-year-old Missouri resident takes immunosuppressant medication for lupus. Consequently, her body has mounted virtually no antibody response to the coronavirus vaccine – leaving her in persistent peril.... ...In August, the FDA granted further...

Washington bureaucrats, who are basically controlled by the big pharmaceutical companies, have refused to recognize these safe, inexpensive, and effective therapeutics in the fight against C-19. While the bureaucrats have persistently offered no preventative or early intervention therapeutics, they have pushed the ineffective and dangerous drug Remdesivir once a person has been hospitalized. However, one experimental drug that has received FDA Emergency Use Authorization (EUA) is Regeneron, a monoclonal antibody. The approval is only for out-patient treat during the first ten days of symptoms. Texas has been quietly making this treatment available for several months through Infusion Centers, but because...

just saw videos today of an abortionist admitting Regeneron is created by dissecting the liver out from a fetus with a live heart. This liver is then used to "humanize" a mouse for further ingredients. How can we possibly support such a demon drug? Certainly not for the right reasons, but Joe did the right thing.

This link should take you to the relevant spot (4:20:07):FDA: Vaccines and Related Biological Products Advisory Committee meeting"

President Joe Biden’s decision to cut deliveries of monoclonal antibodies to southeastern states, in what critics have called a politically-motivated effort to punish Republican states, could end up sentencing black people to death from coronavirus. On Tuesday, Politico reported that the Biden administration was going to ration the distribution of monoclonal antibodies from Regeneron, given that “demand from a handful of southern states … accounted for 70 percent of all orders in early September.” Texas, Georgia, and Florida are the three U.S. states with the largest number of black residents. Black residents are also a large proportion of residents in...

In response to the Biden administration’s new policy of limiting shipments of monoclonal antibody treatments to certain states that have leaned heavily on the treatment, Florida Gov. Ron DeSantis (R) said his state will circumvent the policy and just buy more treatments. Speaking with reporters on Thursday, DeSantis said he had a call with GlaxoSmithKline executives this week and is confident Florida will be able to order monoclonal antibody treatments directly from the company. Previously, Florida had used monoclonal antibody treatments from Regeneron, which had a direct purchasing agreement with the federal government. “I had a call yesterday with GlaxoSmithKline...

Looks like Rep. Roy is the only one who contacted HHS regarding they're "take-over" of Monoclonal antibody distribution. Wanted to contact to support him but am not in his state.

The Biden administration this week slashed the doses of lifesaving coronavirus antibody treatment to Florida, giving the state less than half of what is needed for a routine week, prioritizing “equitable distribution” — a move some suspect is a form of revenge against Republican governors whom the president vowed to get “out of the way.” The Biden administration this week began to cut the distribution of monoclonal antibodies to red states, such as Florida and Alabama, contending those states, including Texas, Mississippi, Tennessee, Georgia, and Louisiana, are comprising too big a share of the supply in recent weeks — 70...